本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Ascendis Pharma A/S

230.76
+1.510.66%
成交量:15.43萬
成交額:3,532.15萬
市值:143.80億
市盈率:-52.24
高:230.89
開:227.91
低:226.70
收:229.25
52周最高:248.60
52周最低:124.06
股本:6,231.61萬
流通股本:6,008.34萬
量比:0.46
換手率:0.26%
股息:- -
股息率:- -
每股收益(TTM):-4.4176
每股收益(LYR):-4.4176
淨資產收益率:-818.43%
總資產收益率:-6.86%
市淨率:-76.52
市盈率(LYR):-52.24

資料載入中...

2025/02/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/12

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/12/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/12

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/08

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/09/04

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans